This supports our findings in the pre-clinical studies that SRPK1 is a determinant of angiogenesis in PCa, as such it would not affect cell morphology (and therefore Gleason score) but contribute to its aggressiveness by stimulating angiogenesis. This evidence concerns the gene SRPK1 and posterior cortical atrophy.